About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gna13tm2.1Soff
targeted mutation 2.1, Stefan Offermanns
MGI:3697690
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Tek-icre/ERT2)1Soff/?
involves: 129P2/OlaHsd * 129S1/Sv * FVB/N MGI:3837460
cn2
Cd19tm1(cre)Cgn/Cd19+
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N MGI:3699320
cn3
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
involves: 129S1/Sv * C57BL/6 * CBA MGI:3849203
cn4
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
involves: 129S1/Sv * C57BL/6 * CBA * FVB/N MGI:3699352
cn5
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
X/Tg(Myh11-icre/ERT2)1Soff
involves: 129S1/Sv * FVB/N MGI:3819345
cn6
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
involves: C57BL/6 * CBA * FVB/N MGI:3699351


Genotype
MGI:3837460
cn1
Allelic
Composition
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Tek-icre/ERT2)1Soff/?
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gna12tm1Citb mutation (0 available); any Gna12 mutation (21 available)
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
Tg(Tek-icre/ERT2)1Soff mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
N
• tamoxifen-treated mice respond similar to wild-type controls in experiments testing response to anaphylactic shock




Genotype
MGI:3699320
cn2
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Genetic
Background
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (57 available)
Gna12tm1Citb mutation (0 available); any Gna12 mutation (21 available)
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• marginal zone B cell numbers are strongly reduced compared to controls
• lysophospholipid-induced induced adhesion is completely abrogated in marginal zone mutant B cells and is reduced in follicular B cells
• lysophospholipid-induced induced LFA-1 (integrin) clustering is abolished in mutant B cells

immune system
• marginal zone B cell numbers are strongly reduced compared to controls
• lysophospholipid-induced induced adhesion is completely abrogated in marginal zone mutant B cells and is reduced in follicular B cells
• lysophospholipid-induced induced LFA-1 (integrin) clustering is abolished in mutant B cells




Genotype
MGI:3849203
cn3
Allelic
Composition
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gna12tm1Citb mutation (0 available); any Gna12 mutation (21 available)
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• homeostatic CD4+ T cell proliferation is increased within the lymph nodes
• allogenic stimulation of CD4+ T cells is also increased
• thymus weight and cellularity is increased by about a third
• CD4+ T cell numbers in the lymph nodes and blood are increased by about a third
• CD8+ T cell numbers in the lymph nodes are slightly increased
• CD4+ T cells have longer interactions between themselves and with allogenic dendritic cells
• CD4+ T cells have a higher affinity for ICAM-coated surfaces
• CD4+ T cells have decreased motility through transwell filters
• CD4+ T cells transferred into wild-type mice have enhanced enhanced transendothelial migration into lymph nodes
• axillary, cervical, inguinal and mesenteric lymph nodes are increased in weight and cell number by about a third
• an increase in ear thickness is observed after sensitization and challenge with DNFB
• CD4+ T cells in cervical lymph nodes have a higher proliferation rate than those of control mice after DNFB challenge
• IL-2 secretion is enhanced by CD4+ T cells in response to allogenic stimulation
• diabetes development is accelerated and aggravated after streptozotocin induction with high glucose levels detected
• peripancreatic lymph nodes are enlarged 5-6 days after disease induction
• increased numbers of CD4+ T cells are noted in the pancreas 14 days after disease induction compared to controls

hematopoietic system
• homeostatic CD4+ T cell proliferation is increased within the lymph nodes
• allogenic stimulation of CD4+ T cells is also increased
• thymus weight and cellularity is increased by about a third
• CD4+ T cell numbers in the lymph nodes and blood are increased by about a third
• CD8+ T cell numbers in the lymph nodes are slightly increased
• CD4+ T cells have longer interactions between themselves and with allogenic dendritic cells
• CD4+ T cells have a higher affinity for ICAM-coated surfaces
• CD4+ T cells have decreased motility through transwell filters
• CD4+ T cells transferred into wild-type mice have enhanced enhanced transendothelial migration into lymph nodes

endocrine/exocrine glands
• thymus weight and cellularity is increased by about a third

cellular
• homeostatic CD4+ T cell proliferation is increased within the lymph nodes
• allogenic stimulation of CD4+ T cells is also increased




Genotype
MGI:3699352
cn4
Allelic
Composition
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gna12tm1Citb mutation (0 available); any Gna12 mutation (21 available)
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• platelet thrombus formation is severely impaired ex vivo after treatment of platelets with polyinosinic-polycytidylic acid (PIPC) to induce recombination
• however, initial adhesion of platelets is similar to wild-type
• serotonin secretion induced by U46619 plus adrenaline or Par-4 peptide exposure is significantly decreased compared to wild-type cells
• however, thrombin-induced serotonin secretion is not impaired
• absence of a shape change in response to low concentration of stimuli compared to wild-type following polyinosinic-polycytidylic acid (PIPC) treatment
• however, shape change is induced with high concentration of stimuli
• potency of agonists to induce aggregation is reduced but aggregation occurs at all agonist concentrations
• potency of agonists to induce aggregation is reduced but aggregation occurs at all agonist concentrations
• very large increase in bleeding time in interferon-responsive tissues
• when bone marrow-derived cells PIPC-treated mice are transplanted into irradiated wild-type mice, 4 weeks later mice have greatly prolonged bleeding times (>20 minutes) compared with mice receiving cells from noninduced controls

hematopoietic system
• serotonin secretion induced by U46619 plus adrenaline or Par-4 peptide exposure is significantly decreased compared to wild-type cells
• however, thrombin-induced serotonin secretion is not impaired
• absence of a shape change in response to low concentration of stimuli compared to wild-type following polyinosinic-polycytidylic acid (PIPC) treatment
• however, shape change is induced with high concentration of stimuli
• potency of agonists to induce aggregation is reduced but aggregation occurs at all agonist concentrations
• potency of agonists to induce aggregation is reduced but aggregation occurs at all agonist concentrations




Genotype
MGI:3819345
cn5
Allelic
Composition
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
X/Tg(Myh11-icre/ERT2)1Soff
Genetic
Background
involves: 129S1/Sv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gna12tm1Citb mutation (0 available); any Gna12 mutation (21 available)
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
Tg(Myh11-icre/ERT2)1Soff mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• tamoxifen-treated mice exhibit decreased blood pressure following treatment with U46619, vasopressin and endothelin compared to in wild-type mice
• tamoxifen-treated mice exposed to DOCA-salt do not develop hypertension and DOCA-salt treated mice exposed to tamoxifen following the onset of hypertension exhibit a drop in blood pressure compared to in similarly treated wild-type mice
• tamoxifen-treated mice exhibit reduced vasocontraction in response to angiotensin II, U46619 and endothelin-1 compared to in similarly treated wild-type mice

muscle
• tamoxifen-treated mice exhibit reduced vasocontraction in response to angiotensin II, U46619 and endothelin-1 compared to in similarly treated wild-type mice




Genotype
MGI:3699351
cn6
Allelic
Composition
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: C57BL/6 * CBA * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gna13tm2.1Soff mutation (0 available); any Gna13 mutation (12 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• platelet thrombus formation is severely impaired ex vivo after treatment of platelets with polyinosinic-polycytidylic acid (PIPC) to induce recombination
• however, initial adhesion of platelets ex vivo is similar to wild-type
• in wild-type mice transfected with Gna13-deficient bone marrow, after vascular injury no thrombi form
• impairment in shape change and aggregation induced following polyinosinic-polycytidylic acid (PIPC) treatment is identical to that in mice that are also homozygous for Gna12tm1Citb
• serotonin secretion induced by U46619 plus adrenaline or Par-4 peptide exposure is significantly decreased compared to wild-type cells
• however, thrombin-induced serotonin secretion is not impaired
• in wild-type mice transfected with Gna13-deficient bone marrow, platelets adhere to subendothelial surface after injury, but with a ~50% reduction in numbers compared to wild-type platelets
• very large increase in bleeding time in interferon-responsive tissues
• when bone marrow-derived cells PIPC-treated mice are transplanted into irradiated wild-type mice, 4 weeks later mice have greatly prolonged bleeding times (>20 minutes) compared with mice receiving cells from noninduced controls

hematopoietic system
• impairment in shape change and aggregation induced following polyinosinic-polycytidylic acid (PIPC) treatment is identical to that in mice that are also homozygous for Gna12tm1Citb
• serotonin secretion induced by U46619 plus adrenaline or Par-4 peptide exposure is significantly decreased compared to wild-type cells
• however, thrombin-induced serotonin secretion is not impaired
• in wild-type mice transfected with Gna13-deficient bone marrow, platelets adhere to subendothelial surface after injury, but with a ~50% reduction in numbers compared to wild-type platelets





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
06/12/2024
MGI 6.13
The Jackson Laboratory